CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease — Stella

Home/EGFR Activating Mutation/

View on ClinicalTrials.gov

Recruiting

Back to EGFR Activating Mutation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

BC Cancer, Vancouver, British Columbia

Key details

Sponsor

British Columbia Cancer Agency

Enrollment target

~10 participants

Started

July 2022

Primary completion

December 2026

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.